P2292 Efficacy of Endoscopic Gastroplasty for Weight Loss: A Systematic Review and Meta-Analysis

Share
  • Twitter
  • Facebook
  • email
  • StumbleUpon
  • Delicious
  • Google Reader
  • LinkedIn
  • Google Bookmarks

    *EMBARGOED All research presented at the 2018 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Monday, October 8, 2018, at 8:00 am EDT.


    Benjamin Renelus, MD

    Benjamin Renelus, MD

    P2292 Efficacy of Endoscopic Gastroplasty for Weight Loss: A Systematic Review and Meta-Analysis

    Author Insight from Benjamin Renelus, MD, New York-Presbyterian Brooklyn Methodist Hospital

    What’s new and important here?

    Bariatric endoscopy is a rapidly growing field. With rates of obesity continually rising among both children and adults, expanded treatment options are needed. The novelty of endoscopic gastroplasty provides limited overall efficacy and longer-term durability assessment. In order to maximize reporting of the effectiveness of this procedure, a systematic review and meta-analysis was undertaken. To our knowledge, this is the most robust/comprehensive meta-analysis on endoscopic gastroplasty efficacy to date. Our results revealed a six-and-12-month %EBMIL of 41% and 44%, respectively. The six-and-12-month %EWL was 46% for both dates. These figures greatly exceed the one year %EWL recommended for endoscopic procedures by the ASGE/ASMBS Task Force.

    Read the Abstract

    Figure 1

    Figure 2

    Figure 3

    Figure 4

    Author Contact
    Benjamin Renelus, MD, New York-Presbyterian Brooklyn Methodist Hospital
    bdr9004@nyp.org


    Media Interview Requests
    To arrange an interview with any ACG experts or abstract authors, please contact Brian Davis of ACG via email at bdavis@gi.org or by phone at 301-263-9000.

    Share
    • Twitter
    • Facebook
    • email
    • StumbleUpon
    • Delicious
    • Google Reader
    • LinkedIn
    • Google Bookmarks